Coronavirus Update: Warp Speed Companies Grilled On Vaccine Safety, Price And Timelines
Two Companies Commit To Not-For-Profit Supply
House committee seeks reassurances on a range of issues, including the security of a US vaccines supply chain against a background of rising tensions with China.
You may also be interested in...
The US government’s order of 100 million doses for $1.95bn means the implied price for Pfizer/BioNtech's vaccine is $19.50 per dose. That could set a benchmark for solid near-term revenue and profitability for companies in the space.
New board directors named at Autolus Therapeutics, Beximco Pharmaceuticals, Tetraphase Pharmaceuticals and Vesigen.
The study is designed to support the regulatory approval process in China and confirm that the safety and immunogenicity profile observed in German and US trials is comparable to that of Chinese participants, according to BioNTech.